- Multimodality approach towards individualized non-small cell lung cancer treatment
- Award date
- 20 June 2014
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
The different studies described in this thesis focus on better understanding of individualized diagnostics, response evaluation and multi modality treatments in non-small cell lung cancer (NSCLC) patients. In part I the novel biological agents erlotinib and cetuximab are evaluated in a new, multimodality treatment setting in resectable and locally advanced patients, respectively. Part II focuses on improving radiotherapy by mediastinal lymph node position variability analysis and image guided corrections, in locally advanced NSCLC.
- Research conducted at: Netherlands Cancer Institute/Antoni van Leeuwenhoek
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.